Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Ethics 2001;27:151-156; doi:10.1136/jme.27.3.151
Copyright © 2001 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.
J Med Ethics 2001; 27:151-156
© 2001 the Journal of Medical Ethics

Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?

Wim Dekkers and Gerard Boer

University Medical Centre, Nijmegen, the Netherlands and Netherlands Institute for Brain Research, Amsterdam, the Netherlands

Abstract

For a few decades, patients with Parkinson's disease (PD) have been treated with intracerebral transplantations of fetal mesencephalic tissue. The results of open trials have been variable. Double blind, placebo-controlled studies have recently been started in order to further investigate the efficacy of this new medical technique. In this paper we challenge the need for sham surgery in neurotransplantation research on PD patients. Considerations regarding the research subjects' informed consent, therapeutic misconception, the integrity of the human body, and the assessment of risks and benefits argue against sham surgery for patients with PD. Moreover, there is an alternative, less harmful mode of research that can provide the same or comparable scientific evidence. A plea is made for intrapatient research based on quantitative measurements of the patient's pre- and post-operative condition combined with similar research on a reference group of patients who have received the standard treatment.

Key Words: Neural grafting • Parkinson's disease • research ethics • sham surgery


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Rascol, O. (2005). Assessing the risk of a necessary harm: Placebo surgery in Parkinson disease. Neurology 65: 982-983 [Full Text]  
  • Moreira, T., Palladino, P. (2005). Between truth and hope: on Parkinson's disease, neurotransplantation and the production of the 'self'. History of the Human Sciences 18: 55-82 [Abstract]  
  • Albin, R L (2005). Sham surgery controls are mitigated trolleys. J. Med. Ethics 31: 149-152 [Abstract] [Full Text]  
  • Miller, F. G, Kaptchuk, T. J (2004). Sham procedures and the ethics of clinical trials. JRSM 97: 576-578 [Full Text]  
  • Stirrat, G M (2004). Ethics and evidence based surgery. J. Med. Ethics 30: 160-165 [Abstract] [Full Text]  
  • Rosser, A E, Barker, R A, Harrower, T, Watts, C, Farrington, M, Ho, A K, Burnstein, R M, Menon, D K, Gillard, J H, Pickard, J, Dunnett, S B (2002). Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 73: 678-685 [Abstract] [Full Text]  
  • Albin, R L (2002). Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. J. Med. Ethics 28: 322-325 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.